Assessing iron status: beyond serum ferritin and transferrin saturation

scientific article published on September 2006

Assessing iron status: beyond serum ferritin and transferrin saturation is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.2215/CJN.01490506
P698PubMed publication ID17699374
P5875ResearchGate publication ID6141053

P2093author name stringJay B Wish
P921main subjectironQ677
P304page(s)S4-8
P577publication date2006-09-01
P1433published inClinical Journal of the American Society of NephrologyQ15757929
P1476titleAssessing iron status: beyond serum ferritin and transferrin saturation
P478volume1 Suppl 1

Reverse relations

cites work (P2860)
Q35998091A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Q42285098Absolute and Functional Iron Deficiency Anemia among Different Tumors in Cancer Patients in South Part of Iran, 2014
Q57175195Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome
Q43923945Anaemia and iron deficiency in heart failure: epidemiological gaps, diagnostic challenges and therapeutic barriers in sub-Saharan Africa
Q42293553Anaemia in inflammatory bowel disease
Q28069820Anemia and iron deficiency in gastrointestinal and liver conditions
Q37737810Anemia and transfusions in geriatric patients: a time for evaluation
Q34782520Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis.
Q37627538Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis
Q42112719Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis.
Q34564073Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data
Q58748590Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
Q37462055Association of hepcidin-25 with survival after kidney transplantation.
Q38170331Association of iron indices and type 2 diabetes: a meta-analysis of observational studies
Q37389742Associations between Lifestyle Factors and Iron Overload in Korean Adults.
Q64968719Associations of genetically determined iron status across the phenome: A mendelian randomization study.
Q37776267Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis
Q34169748Biological and clinical aspects of soluble transferrin receptor
Q42182081Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis
Q35012284Blood transfusion, serum ferritin, and iron in hemodialysis patients in Africa
Q33684085Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
Q36431188Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis
Q35244441Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease
Q86906439Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis
Q95271262Correlates of Nonanemic Iron Deficiency in Restless Legs Syndrome
Q39019386Current evaluation and management of anemia in patients with inflammatory bowel disease
Q38151564Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide
Q36302219Decisive indicator for gastrointestinal workup in anemic patients with nondialysis chronic kidney disease
Q36349371Deranged iron status in psoriasis: the impact of low body mass.
Q91235641Detection of iron deficiency in children with Down syndrome
Q39192941Diagnosing and preventing iron overload
Q37937176Diagnosing anemia in inflammatory bowel disease: beyond the established markers
Q34141999Diagnosis and management of iron deficiency anemia in patients with IBD.
Q35018420Diagnosis and management of iron deficiency anemia in the 21st century
Q38058415Diagnosis of anaemia: old things rearranged
Q43137967Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia
Q50266795Effect of intravenous iron on outcomes of acute kidney injury
Q46083931Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial
Q91924358Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study
Q87820193Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency
Q50570321Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty.
Q51753810Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
Q37403306Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
Q86102619Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers?
Q33658410Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective
Q92682745Evaluation of Iron Status in Patients of Chronic Kidney Disease - A Study to Assess the Best Indicators Including Serum Transferrin Receptor Assay
Q28538067Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study
Q36841741Ferritin Levels in Colombian Children: Findings from the 2010 National Nutrition Survey (ENSIN)
Q24642942Ferritin for the clinician
Q47994810Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin
Q41474865Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells
Q38657755Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging
Q42276038HWA: Hypoferritinemia without anemia a hidden hematology disorder
Q43798489Hematological variables and iron status in abdominoplasty after bariatric surgery
Q36366398Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis
Q41825275Hemoglobin level as a risk factor for lower respiratory tract infections in Lebanese children
Q37211057Hepcidin--a potential novel biomarker for iron status in chronic kidney disease
Q28727076Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents
Q47156054High Neonatal Blood Iron Content Is Associated with the Risk of Childhood Type 1 Diabetes Mellitus.
Q101041624High Soluble Transferrin Receptor in Patients With Heart Failure: a Measure of Iron Deficiency And a Strong Predictor of Mortality
Q52949564High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.
Q55287039Implementation of a patient blood management program in an Australian private hospital orthopedic unit.
Q36552989Increased Body Mass Index may lead to Hyperferritinemia Irrespective of Body Iron Stores
Q89127050Increased NGAL level associated with iron store in chronic kidney disease with anemia
Q92446436Intravenous iron therapy in heart failure: a different perspective
Q47102798Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions
Q84250704Intravenous iron therapy is the option for RA patient with absolute iron deficiency accompanied with functional iron deficiency
Q57170016Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release
Q89636084Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Q90667866Iron Status and Risk of Stroke
Q33700880Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
Q90672995Iron and Heart Failure: Diagnosis, Therapies, and Future Directions
Q42180857Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia
Q39371536Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
Q38551016Iron deficiency and cardiovascular disease
Q36682182Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
Q47708845Iron deficiency and red cell indices in patients with heart failure
Q54380664Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.
Q40573772Iron deficiency anemia and megaloblastic anemia in obese patients.
Q33822956Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment
Q48716818Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
Q51114270Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis
Q56968591Iron deficiency in chronic heart failure: case-based practical guidance
Q38384454Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomes
Q27023196Iron deficiency in gastrointestinal oncology
Q38142571Iron deficiency in heart failure: a practical guide
Q99365535Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases
Q36619022Iron deficient erythropoiesis might play key role in development of anemia in cancer patients
Q49103122Iron isotopic composition of blood serum in anemia of chronic kidney disease
Q36371665Iron metabolism and iron supplementation in cancer patients
Q37992243Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis
Q37331361Iron status and survival in diabetic patients with coronary artery disease
Q36971596Iron status in patients with chronic heart failure
Q51025555Iron supplementation prevents a decline in iron stores and enhances strength performance in elite female volleyball players during the competitive season.
Q38264186Is iron treatment beneficial in, iron-deficient but non-anaemic (IDNA) endurance athletes? A systematic review and meta-analysis
Q47943865Is it time for hepcidin to join the diagnostic toolkit for iron deficiency?
Q50998053Long-Term Trends in Hematological and Nutritional Status After Gastrectomy for Gastric Cancer.
Q51032568Long-term stability of biomarkers of the iron status in human serum and plasma.
Q92170714Low frataxin mRNA expression is associated with inflammation and oxidative stress in patients with type 2 diabetes
Q51552053Low hemoglobin density potential marker of iron availability.
Q33853010Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study
Q38431492Low transferrin saturation is associated with impaired fasting glucose and insulin resistance in the South Korean adults: the 2010 Korean National Health and Nutrition Examination Survey
Q50060591Management of Anemia in Patients with Inflammatory Bowel Disease (IBD).
Q47821861Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.
Q42766145Markers of iron metabolism in retired racing Greyhounds with and without osteosarcoma
Q38887263Markers of iron status in chronic kidney disease
Q52581674Measurement of iron status in chronic kidney disease.
Q43677689Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease
Q36450638Mechanism of anemia in Schistosoma mansoni-infected school children in Western Kenya
Q37563605Metals in the pathogenesis of type 2 diabetes
Q92462134Monitoring of iron status in patients with heart failure
Q57191817Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
Q37893439Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease
Q39002211Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery
Q50240951Percentage of hypochromic erythrocytes and reticulocyte hemoglobin equivalent predictors of response to intravenous iron in hemodialysis patients
Q47348851Physical exercise intervention at school improved hepcidin, inflammation, and iron metabolism in overweight and obese children and adolescents.
Q51066665Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
Q47129994Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease
Q46049718Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis
Q33720452Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry
Q27004170Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron
Q36950488Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia
Q34785164Prohepcidin levels in refractory anaemia caused by lead poisoning
Q64093853Red Blood Cell Variables in Children and Adolescents regarding the Age and Sex
Q35665003Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure
Q98613424Relationship between iron status markers and insulin resistance: an exploratory study in subjects with excess body weight
Q47835950Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.
Q35694046Resistance of dialyzed patients to erythropoietin
Q50913758Retrospective study of reticulocyte indices as indicators of iron-restricted erythropoiesis in dogs with immune-mediated hemolytic anemia.
Q61818280Role of Soluble Transferrin Receptor and Transferrin Receptor-Ferritin Index to Detect Iron Deficiency Anemia in Regular Hemodialysis Patients
Q37161960Safety issues with intravenous iron products in the management of anemia in chronic kidney disease
Q24626621Serum ferritin: Past, present and future
Q37647139Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study
Q64103057Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin
Q90618470T2 ∗ Relaxation Time Obtained from Magnetic Resonance Imaging of the Liver Is a Useful Parameter for Use in the Construction of a Murine Model of Iron Overload
Q37631132The Effects of Nutrition, Exercise, and a Praying Program on Reducing Iron Overload in Patients With Beta-Thalassemia Major: A Randomized Clinical Trial.
Q90024553The Effects of Psychological and Environmental Stress on Micronutrient Concentrations in the Body: A Review of the Evidence
Q37668885The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
Q92959917The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
Q47793807The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery
Q37542851The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients
Q35088131The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis
Q37405665The transplant iron score as a predictor of stem cell transplant survival
Q46801018The utility of reticulocyte indices in distinguishing iron deficiency anemia from anemia of inflammatory disease, portosystemic shunting, and breed-associated microcytosis in dogs
Q93159789The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening iron-deficiency anemia among patients with end-stage renal disease: a retrospective analysis
Q35130666Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Q35996211Understanding renal posttransplantation anemia in the pediatric population
Q57040818Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa
Q53102532Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Search more.